Marine Pharmacology
A section of Marine Drugs (ISSN 1660-3397).
Section Information
Considering that oceans cover approximately 70% of our planet, there are huge untapped marine resources available for the discovery of future therapeutic applications. For example, several marine drugs have been shown to affect basically all hallmarks of cancer and even to contribute to epigenetic reprogramming, although selected cell signaling pathways remain to be further investigated.
This Section of Marine Drugs aims to provide a comprehensive and advanced publication platform for studies concerning all aspects of marine pharmacology, including approved marine-drug-related reports, the pharmacological characterization of marine compounds or their derivatives, preclinical and clinical pharmacological studies on marine-derived compounds, and the development of marine-derived drugs as well as marine-derived pharmaceutical formulations.
Scope
- Discovery and development of marine-derived drugs
- Marine-derived drug leads
- Preclinical research on marine-derived drugs
- Clinical research on marine-derived drugs
- Reports of approved marine-derived drugs
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Marine Immunomodulatory Compounds (Deadline: 25 September 2023)
- Marine Anti-inflammatory and Antioxidant Agents 3.0 (Deadline: 26 September 2023)
- Microalgae, Brain Health and Aging (Deadline: 30 September 2023)
- Marine Bioactive Compounds against Oxidative Stress and Inflammation (Deadline: 30 September 2023)
- Fatty Acids from Marine Organisms (Deadline: 30 September 2023)
- Marine Natural Products with Anti-obesity and Antidiabetic Potentials (Deadline: 30 September 2023)
- Metabolic and Neurologic Diseases and Marine Natural Products (Deadline: 18 October 2023)
- Marine Antiparasitic Agents (Deadline: 31 October 2023)
- Biomedical Application of Marine-Derived Carbohydrates (Deadline: 31 October 2023)
- Recent Advances in Marine-Derived Pigments (Deadline: 31 October 2023)
- Marine Drugs in Cell Signaling Pathways 2nd Edition (Deadline: 31 October 2023)
- Antimicrobial and Antiviral Agents from Marine Sources 2nd Edition (Deadline: 31 October 2023)
- Marine Drug Development and Pre-clinical Studies for Infection and Inflammation (Deadline: 31 October 2023)
- Enzyme Inhibitors from Marine Resources (Deadline: 31 October 2023)
- Marine Antimicrobial Peptides (Deadline: 20 November 2023)
- Marine-Derived Compounds Applied in Cardiovascular Disease (Deadline: 30 November 2023)
- Marine Natural Products with Anti-Inflammatory Effects (Deadline: 30 November 2023)
- Marine Natural Products, Gut Microbiota and Health Benefits (Deadline: 30 November 2023)
- Therapeutic Potential of Marine Polyphenols (Deadline: 30 November 2023)
- Marine Lectins 2nd Edition (Deadline: 30 November 2023)
- Fucoidans: From Production to Application (Deadline: 30 November 2023)
- Bioactive Product from Marine Cyanobacteria (Deadline: 31 December 2023)
- Marine Natural Products with Hypolipidemic Activity (Deadline: 31 December 2023)
- Exploring Marine-Inspired Drugs for New Therapies against Resistant and Metastatic Cancers (Deadline: 31 December 2023)
- Marine Drugs Research in Spain 2nd Edition (Deadline: 31 December 2023)
- Bioactive Compounds from Micro- and Macroalgae for Marine Drug Applications: Optimization of Upstream and Downstream Processes (Deadline: 31 December 2023)
- Collagen and Bioactives from Marine By-Products (Deadline: 31 December 2023)
- Bioactive Compounds from Natural Immune Systems of Marine Invertebrates (Deadline: 31 December 2023)
- Marine Natural Products as Anticancer Agents 3.0 (Deadline: 31 January 2024)
- Marine Bioactive Substances: Implicated with Senescence-Related Disease (Deadline: 31 January 2024)
- Marine Bioactive Compounds with Neuroprotective Potential (Deadline: 31 January 2024)
- Poly- and Oligosaccharides from Marine Origins (Deadline: 31 January 2024)
- Pharmacological Potential of Marine Natural Products (Deadline: 31 January 2024)
- Bioactive Metabolites from Marine-Derived Penicillium or Aspergillus Species (Deadline: 15 February 2024)
- Marine Fucosylated Chondroitin Sulfates (Deadline: 29 February 2024)
- Discovery of Marine-Derived Anticancer Agents (Deadline: 29 February 2024)
- Bio-Active Components from Marine Sponges (Deadline: 29 February 2024)
- Marine Natural Products and Signaling Pathways (Deadline: 29 February 2024)
- Marine Natural Products and Liver Health (Deadline: 29 February 2024)
- Polysaccharides from Marine Environment (Deadline: 15 March 2024)
- Natural Products Isolated from Marine Sediment (Deadline: 31 March 2024)
- Advances in Marine-Derived Fucoxanthin Studies (Deadline: 31 March 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
